<VariationArchive VariationID="496732" VariationName="NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs)" VariationType="Duplication" Accession="VCV000496732" Version="18" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-15" DateCreated="2018-08-17" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488178" VariationID="496732">
      <GeneList>
        <Gene Symbol="CYP26C1" FullName="cytochrome P450 family 26 subfamily C member 1" GeneID="340665" HGNC_ID="HGNC:20577" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q23.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="93060798" stop="93069540" display_start="93060798" display_stop="93069540" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="94821020" stop="94828453" display_start="94821020" display_stop="94828453" Strand="+" />
          </Location>
          <OMIM>608428</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs)</Name>
      <CanonicalSPDI>NC_000010.11:93064519:CCATGCA:CCATGCACCATGCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q23.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="93064519" stop="93064520" display_start="93064519" display_stop="93064520" variantLength="7" positionVCF="93064519" referenceAlleleVCF="T" alternateAlleleVCF="TCCATGCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="94824276" stop="94824277" display_start="94824276" display_stop="94824277" variantLength="7" positionVCF="94824276" referenceAlleleVCF="T" alternateAlleleVCF="TCCATGCA" />
      </Location>
      <OtherNameList>
        <Name>p.Gln284HisfsX129</Name>
      </OtherNameList>
      <ProteinChange>Q284fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.94824277_94824283dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.94824277_94824283dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.93064520_93064526dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.93064520_93064526dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007958.1" sequenceAccession="NG_007958" sequenceVersion="1" change="g.8257_8263dup">
            <Expression>NG_007958.1:g.8257_8263dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183374.3" sequenceAccession="NM_183374" sequenceVersion="3" change="c.845_851dup" MANESelect="true">
            <Expression>NM_183374.3:c.845_851dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_899230.2" sequenceAccession="NP_899230" sequenceVersion="2" change="p.Gln284fs">
            <Expression>NP_899230.2:p.Gln284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1290" sequenceAccession="LRG_1290">
            <Expression>LRG_1290:g.8257_8263dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1290t1" sequenceAccession="LRG_1290t1">
            <Expression>LRG_1290t1:c.845_851dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1290p1" sequenceAccession="LRG_1290p1" change="p.Gln284fs">
            <Expression>LRG_1290p1:p.Gln284fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183374.2" sequenceAccession="NM_183374" sequenceVersion="2" change="c.845_851dupCCATGCA">
            <Expression>NM_183374.2:c.845_851dupCCATGCA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608428.0001" DB="OMIM" />
        <XRef Type="rs" ID="565866662" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="variation affecting protein">
        <XRef ID="0002" DB="Variation Ontology" />
      </FunctionalConsequence>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00078" Source="1000 Genomes Project 30x" />
        <AlleleFrequency Value="0.00080" Source="1000 Genomes Project" />
        <AlleleFrequency Value="0.00141" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00152" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00211" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00212" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00224" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.00080" Source="1000 Genomes Project" MinorAllele="CCATGCACCATGCA" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs) AND Optic nerve hypoplasia" Accession="RCV000677253" Version="3">
        <ClassifiedConditionList TraitSetID="28198">
          <ClassifiedCondition DB="MedGen" ID="C0338502">Optic nerve hypoplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs) AND not provided" Accession="RCV000968474" Version="11">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs) AND not specified" Accession="RCV000825029" Version="4">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-20" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_183374.3(CYP26C1):c.845_851dup (p.Gln284fs) AND Focal facial dermal dysplasia type IV" Accession="RCV002285162" Version="1">
        <ClassifiedConditionList TraitSetID="9170">
          <ClassifiedCondition DB="MedGen" ID="C3554246">Focal facial dermal dysplasia type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-02-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2018-08-17" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1); Likely benign(2)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">16530710</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23161670</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29263414</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32040484</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1); Likely benign(2)</Comment>
        <DescriptionHistory Dated="2022-09-28">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-09-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-08-25">
          <Description>Likely benign</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="28198" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17180" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Optic nerve hypoplasia</ElementValue>
                <XRef ID="HP:0000609" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0338502" DB="MedGen" />
              <XRef Type="primary" ID="HP:0000609" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007273" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9170" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Focal facial dermal dysplasia type IV</ElementValue>
                <XRef ID="MONDO:0013997" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Focal facial dermal dysplasia 4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FFDD4</ElementValue>
                <XRef Type="MIM" ID="614974" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17650" />
                <XRef ID="17650" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="398166" DB="Orphanet" />
              <XRef ID="398189" DB="Orphanet" />
              <XRef ID="C3554246" DB="MedGen" />
              <XRef ID="MONDO:0013997" DB="MONDO" />
              <XRef Type="MIM" ID="614974" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="94054" SubmissionDate="2019-12-18" DateLastUpdated="2013-09-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608428.0001_FOCAL FACIAL DERMAL DYSPLASIA 4" title="CYP26C1, 7-BP DUP, NT844_FOCAL FACIAL DERMAL DYSPLASIA 4" />
        <ClinVarAccession Accession="SCV000056850" DateUpdated="2013-09-20" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a sister and brother with focal facial dermal dysplasia-4 (FFDD4; 614974), Slavotinek et al. (2013) identified compound heterozygosity for a 7-bp tandem duplication (844_851dupCCATGCA) in exon 4 of the CYP26C1 gene, causing a frameshift predicted to result in the incorporation of 128 different amino acids from wildtype residue 284 and then premature termination before residue 412, and a 1433A-G transition in exon 6 that results in an arg478-to-his (R478H; 608428.0002) substitution within the L-helix domain. Their unaffected parents were each heterozygous for 1 of the mutations, neither of which was found in 2 unaffected sibs. Sequencing revealed homozygosity for the 7-bp duplication in 3 additional FFDD4 patients: a previously unreported Belgian girl, as well as a Flemish girl and a Norwegian boy who were originally described by Prescott et al. (2006). The R478H mutation was not found in the Exome Variant Server containing data from more than 10,000 individuals. However, the duplication, which was not present in the dbSNP or 1000 Genomes Project databases or in 200 control chromosomes of Hispanic ethnicity, was detected in 1 (0.4%) of 318 Caucasian chromosomes and in 1 (0.3%) of 236 chromosomes from individuals with eye or diaphragmatic birth defects, for an overall frequency of 2 (0.3%) in 754 chromosomes, suggesting that the FFDD4 phenotype might be nonpenetrant or underascertained. Transfection studies in COS-1 cells demonstrated that both mutations caused loss of CYP26C1 function.</Attribute>
              <Citation>
                <ID Source="PubMed">23161670</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">16530710</ID>
              </Citation>
              <XRef DB="OMIM" ID="614974" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1" />
          </GeneList>
          <Name>CYP26C1, 7-BP DUP, NT844</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7-BP DUP, NT844</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608428.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FOCAL FACIAL DERMAL DYSPLASIA 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1372459" SubmissionDate="2018-02-27" DateLastUpdated="2018-08-17" DateCreated="2018-08-17">
        <ClinVarSubmissionID localKey="SUB3677772" submittedAssembly="GRCh37" title="SUB3677772" />
        <ClinVarAccession Accession="SCV000681430" DateUpdated="2018-08-17" DateCreated="2018-08-17" Type="SCV" Version="1" SubmitterName="Rare Disease Group, Clinical Genetics, Karolinska Institutet" OrgID="506202" OrganizationCategory="laboratory" OrgAbbreviation="RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina XTen</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1">
              <Name>cytochrome P450 family 26 subfamily C member 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_183374.2:exon 4</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs565866662" />
          </XRefList>
          <FunctionalConsequence Value="variation affecting protein">
            <XRef DB="Variation Ontology" ID="0002" URL="http://purl.obolibrary.org/obo/VariO_0002" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_183374.2:c.845_851dupCCATGCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HPO" ID="HP:0000609" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3677772</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7357358" SubmissionDate="2023-06-28" DateLastUpdated="2023-07-01" DateCreated="2023-07-01">
        <ClinVarSubmissionID localKey="GDXSV:277528" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003935703" DateUpdated="2023-07-01" DateCreated="2023-07-01" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect with this variant demonstrating 4% of enzyme activity as compared to wild-type (Slavotinek et al., 2013); Frameshift variant predicted to result in protein truncation as the last 239 amino acids are replaced with 128 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 23161670, 32040484, 34426522, 29263414)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:740896</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_183374.2:c.845_851dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_200_20230628054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894020" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="92397994|not specified" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966226" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23161670</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29263414</ID>
          </Citation>
          <Comment>Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gln284His fsX129 variant in CYP26C1 has been reported in 3 homozygous and 2 compound heter ozygous individuals with focal facial dermal dysplasia 4 (FFDD 4)and segregated with disease in 1 affected relative (Slavotinek 2013, Lee 2018). This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 284 and leads to a premature termination codon 129 amino acids downstream. This termination codon occurs within the terminal 50 bases of the second to last exon and is, therefore, likely to escape nonsense mediated de cay (NMD) and result in a truncated protein. This variant has also been identifi ed in 0.7% (177/25112) of Finnish and 0.3% (392/128808) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org), which is higher than expected cons idering the rarity of FFDD 4. It has been speculated that this is due to incompl ete penetrance or under ascertainment (Slavotinek 2013); however, it is unclear at this time. In summary, while there is some suspicion for a pathogenic role, t he clinical significance of the p.Gln284HisfsX129 variant is uncertain due to co nflicting data. ACMG/AMP Criteria applied: PM3, PM4, BS1_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_183374.2:EXON 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_183374.2:c.845_851dupCCATGCA</Name>
            <Name>p.Gln284HisfsX129</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.94824283_94824284insCCATGCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2083852" SubmissionDate="2020-01-29" DateLastUpdated="2020-05-04" DateCreated="2019-12-17">
        <ClinVarSubmissionID localKey="2153618|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001115932" DateUpdated="2020-05-04" DateCreated="2019-12-17" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_183374.2:c.845_851dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6897608</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8772853" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2024-03-10">
        <ClinVarSubmissionID localKey="180058|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004698409" DateUpdated="2024-07-15" DateCreated="2024-03-10" Type="SCV" Version="5" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>CYP26C1: PVS1, PM2, PM3, PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP26C1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="TCCATGCA" referenceAllele="T" start="94824276" stop="94824276" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7357358" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2083852" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894020" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="94054" TraitType="Disease" MappingType="Name" MappingValue="FOCAL FACIAL DERMAL DYSPLASIA 4" MappingRef="Preferred">
        <MedGen CUI="C3554246" Name="Focal facial dermal dysplasia type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8772853" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1372459" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000609" MappingRef="HPO">
        <MedGen CUI="C0338502" Name="Optic nerve hypoplasia" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001524169</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

